Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2024-12-19 00:00:00 ET · period of report 2024-10-05 · accession 0001415889-24-029909 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-19 | 2024-10-05 | TLSI | Cox Bryan F. | CHIEF SCIENTIFIC, MANUFACT | S - Sale | $4.44 | -314 | 86.4K | -0.4% | -$1,394 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-05 | S | D | 314 | $4.44 | 86,382 | D | — | — |